Authors: | Abrey, L. E.; Rosenblum, M. K.; Papadopoulos, E.; Childs, B. H.; Finlay, J. L. |
Article Title: | High dose chemotherapy with autologous stem cell rescue in adults with malignant primary brain tumors |
Abstract: | High dose chemotherapy (HDCT) with autologous (bone marrow or peripheral blood) stem cell rescue (ASCR) has had success in the treatment of some malignant pediatric brain tumors. We report a series of adults enrolled in one of three HDCT and ASCR protocols for malignant primary brain tumors. Overall toxic mortality was 18%; chemotherapy regimen, tumor type, and prior treatment did not predict transplant-related mortality. Patients over the age of 30 had a higher rate of toxic mortality. Patients with recurrent medulloblastoma had a significant improvement in long-term survival (median: 34 months) as compared with historical reports; two patients with glioblastoma survive beyond four years without progression, but overall, a significant improvement in long-term survival could not be demonstrated for malignant gliomas. |
Keywords: | adolescent; adult; cancer survival; clinical article; treatment outcome; middle aged; survival analysis; cancer recurrence; salvage therapy; antineoplastic agents; combined modality therapy; chemotherapy; drug megadose; brain tumor; glioma; brain neoplasms; antineoplastic agent; carboplatin; etoposide; stem cell transplantation; hematopoietic stem cell transplantation; dose-response relationship, drug; cancer mortality; carmustine; thiotepa; age; glioblastoma; medulloblastoma; brain cancer; transplantation, autologous; autotransplantation; stem cell rescue; humans; human; male; female; article |
Journal Title: | Journal of Neuro-Oncology |
Volume: | 44 |
Issue: | 2 |
ISSN: | 0167-594X |
Publisher: | Springer |
Date Published: | 1999-09-01 |
Start Page: | 147 |
End Page: | 153 |
Language: | English |
DOI: | 10.1023/a:1006383400353 |
PUBMED: | 10619498 |
PROVIDER: | scopus |
DOI/URL: | |
Notes: | Article -- Export Date: 16 August 2016 -- Source: Scopus |